Product was Escalon Medical’s largest product and service line in fiscal 2025, bringing in $11.51M of $12.05M (96%).
| Product and Service | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Product | $9.98M | $11.56M | $11.42M | $11.51M | ||||
| Service | $722.73K | $624.31K | $556.61K | $531.81K | ||||
| Total | $10.70M | $12.18M | $11.98M | $12.05M |
Escalon Medical brought in $12.05M from its two product and service lines in fiscal 2025, the year ended June 30, 2025. That was up 0.5% from $11.98M in fiscal 2024. Product was the largest at $11.51M (95.6%), ahead of Service at $531.81K (4.4%).
Compared with fiscal 2024, Product grew 0.8% to $11.51M, while Service fell 4.5% to $531.81K. From fiscal 2022 to 2025, combined revenue from these lines grew from $10.70M to $12.05M, a compound annual growth rate of 4.0%. Product's share of the total rose from 93.2% to 95.6%.
Domestic was Escalon Medical’s largest revenue line in fiscal 2024, bringing in $6.36M of $11.98M (53%).
| Concentration Risk Type | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Domestic | $6.26M | $5.72M | $7.04M | $6.36M | ||||
| International | $4.22M | $4.98M | $5.14M | $5.62M | ||||
| Total | $10.47M | $10.70M | $12.18M | $11.98M |
Escalon Medical brought in $11.98M from its two revenue lines in fiscal 2024, the year ended June 30, 2024. That was down 1.6% from $12.18M in fiscal 2023. Domestic was the largest at $6.36M (53.1%), ahead of International at $5.62M (46.9%).
Compared with fiscal 2023, International grew 9.4% to $5.62M, while Domestic fell 9.7% to $6.36M. From fiscal 2021 to 2024, combined revenue from these revenue lines grew from $10.47M to $11.98M, a compound annual growth rate of 4.6%. Domestic's share of the total fell from 59.7% to 53.1%.
Escalon Medical (ESMC) reports its revenue by product and service and by concentration risk type. In fiscal 2025, Product was its largest product and service line, bringing in $11.51M (95.6% of the total), followed by Service at $531.81K (4.4%).
Product was Escalon Medical's largest product and service line in fiscal 2025, bringing in $11.51M, or 95.6% of the $12.05M total across its two product and service lines.
Domestic was Escalon Medical's largest revenue line in fiscal 2024, bringing in $6.36M, or 53.1% of the $11.98M total across its two revenue lines.
Product grew faster than Service in fiscal 2025, up 0.8% from $11.42M to $11.51M. Service fell 4.5% to $531.81K.
Every figure comes from Escalon Medical's annual financial filings, as reported. Each line keeps the name Escalon Medical gives it, and years follow its fiscal calendar.
Escalon Medical's revenue by product and service goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.